WallStreetZenWallStreetZen

NASDAQ: AKBA
Akebia Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for AKBA

Based on 2 analysts offering 12 month price targets for Akebia Therapeutics Inc.
Min Forecast
$4.00+191.97%
Avg Forecast
$5.00+264.96%
Max Forecast
$6.00+337.96%

Should I buy or sell AKBA stock?

Based on 2 analysts offering ratings for Akebia Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AKBA stock forecasts and price targets.

AKBA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2023-11-29

1 of 1

Forecast return on equity

Is AKBA forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is AKBA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AKBA revenue forecast

What is AKBA's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$189.6M-2.59%
Avg 2 year Forecast
$157.9M-18.85%
Avg 3 year Forecast
$237.4M+21.98%
AKBA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AKBA revenue growth forecast

How is AKBA forecast to perform vs Biotechnology companies and vs the US market?
Company
3.99%
Industry
37.57%
Market
10.16%
AKBA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AKBA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AKBA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AKBA$1.37$5.00+264.96%Strong Buy
RENB$2.02N/AN/A
EPIX$6.40$17.00+165.63%Buy
VRCA$6.85$10.33+50.85%Strong Buy
ADAP$1.14N/AN/A

Akebia Therapeutics Stock Forecast FAQ

Is Akebia Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AKBA) stock is to Strong Buy AKBA stock.

Out of 2 analysts, 1 (50%) are recommending AKBA as a Strong Buy, 1 (50%) are recommending AKBA as a Buy, 0 (0%) are recommending AKBA as a Hold, 0 (0%) are recommending AKBA as a Sell, and 0 (0%) are recommending AKBA as a Strong Sell.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.

What is AKBA's revenue growth forecast for 2024-2026?

(NASDAQ: AKBA) Akebia Therapeutics's forecast annual revenue growth rate of 3.99% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Akebia Therapeutics's revenue in 2024 is $194,623,000.On average, 2 Wall Street analysts forecast AKBA's revenue for 2024 to be $39,693,842,756, with the lowest AKBA revenue forecast at $39,385,018,650, and the highest AKBA revenue forecast at $40,002,666,862. On average, 2 Wall Street analysts forecast AKBA's revenue for 2025 to be $33,068,257,114, with the lowest AKBA revenue forecast at $26,359,969,423, and the highest AKBA revenue forecast at $39,776,544,805.

In 2026, AKBA is forecast to generate $49,706,024,946 in revenue, with the lowest revenue forecast at $48,980,550,014 and the highest revenue forecast at $50,431,499,879.

What is AKBA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AKBA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is AKBA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AKBA price target, the average AKBA price target is $5.00, with the highest AKBA stock price forecast at $6.00 and the lowest AKBA stock price forecast at $4.00.

On average, Wall Street analysts predict that Akebia Therapeutics's share price could reach $5.00 by Mar 28, 2025. The average Akebia Therapeutics stock price prediction forecasts a potential upside of 264.96% from the current AKBA share price of $1.37.

What is AKBA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AKBA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.